Next: Hormone Therapy.Keep Those Patients on Treatment Too.
Human Coaching at AI Scale. Patients Who Stay.
Menopause hormone therapy and testosterone are the next two Medication Companions on our roadmap, to run on the same platform as our GLP-1 Companion. Both are therapies meant to run for years, and both lose patients early to side effects that nutrition, exercise and sleep coaching can ease. We are looking for design partners to build them with.
On our roadmap, with design partners wanted.
Same Safe Clinical AI, same practitioner review, same coaches as our GLP-1 program.
Medication Companion
Product roadmap
Available
GLP-1 Companion
First
Menopause hormone therapy
Second
Testosterone therapy
One clinical engine. One protocol system. One coaching infrastructure across medication categories.
2025
the year the FDA removed the boxed warnings on menopause hormone therapy and testosterone
2
companions coming next: menopause hormone therapy first, then testosterone
1
platform: each will be a module on the same engine, protocols and coaching team as GLP-1
Why now
Why hormone therapy is next.
With the boxed warnings gone, telehealth companies are building hormone therapy programs now. Their patients quit for the same kind of reason GLP-1 patients do: side effects that peak early, in a therapy meant to last for years.
01
Long therapies, early dropout
Side effects cluster in the first months, which is exactly when patients decide whether to continue. Every patient who stays is a subscription that keeps running.
02
Coachable side effects
Weight gain, poor sleep, muscle and bone loss, bloating and irritability all respond to nutrition, exercise and sleep coaching. The prescription stays with the prescriber.
03
Same buyers, same platform
The telehealth companies building hormone programs are the ones already prescribing GLP-1. One companion, one integration, one more category.
01 — First
Menopause hormone therapy.
Estrogen and progesterone therapy, plus related menopause prescriptions. Coaching sets expectations for the first months on therapy and runs a menopause-transition program alongside it: sleep, hot-flash triggers, and resistance training for muscle and bone.
Bloating and fluid retention
Feels like weight gain in the first weeks
Sodium and fluid habits, and setting expectations for how long it lasts
Breast tenderness
Uncomfortable and worrying when nobody explains it
Expectation-setting, with any breast change routed straight to the prescriber
Mood swings
Patients feel worse before they feel better
Sleep and alcohol protocols that steady the weeks of adjustment
Sleep disruption and hot flashes
The symptoms that brought them in seem to persist
Sleep routines and hot-flash trigger tracking
Perceived weight gain
Patients blame the therapy for midlife body changes
Resistance training and nutrition for body composition, muscle and bone
Escalated at once to the prescriber: abnormal bleeding, signs of a blood clot or stroke, and breast changes. Supplements are checked for interactions.
02 — Second
Testosterone therapy.
Injectable, topical and oral testosterone. Patients expect visible results, but the medication alone does not build muscle. Coaching makes the results visible through resistance training, fat loss, better sleep and less alcohol, which is what keeps patients on therapy.
No visible result
Therapy alone does not build muscle
Structured resistance training and a nutrition plan for body composition
Water retention and acne
Early changes that patients notice in the mirror
Sodium habits and simple skin-care routines
Irritability
Mood shifts while the dose is being adjusted
Sleep and stress protocols through the adjustment period
Poor sleep and fatigue
Patients started therapy to feel better, not worse
Sleep routines, alcohol reduction and weight protocols
Flagged to the prescriber, never coached: a rising red blood cell count from prescriber-entered labs, signs of sleep apnea, and fertility plans. The prescriber decides what to do.
One patient record
Patients on a GLP-1 and hormones.
A patient starting hormone therapy may already be on a GLP-1. They get one plan, not two: the hormone module stacks on the GLP-1 program, so the coaching, food plan and training account for both drugs at once, from one patient record.
GLP-1 program
Hormone module
One coach, one plan, one record.
Overlapping goals such as protecting muscle, improving sleep and managing weight are coached once. Safety rules from both drugs are checked together before any plan is approved.
Patient journey
How it will work.
The same five steps as our GLP-1 Companion, with protocols specific to each hormone therapy.
01
Intake
Health history, medications, the hormone regimen and any prescriber-entered labs.
02
Safety check
The Clinical Reasoning Engine checks the unified patient record so no plan contradicts another drug or condition.
03
Plan
A nutritionist (Registered Dietitian Nutritionist) and a personal trainer review and approve every plan before the patient sees it.
04
Daily coaching
Meals, training sessions, sleep routines and check-ins, delivered under your brand.
05
Measure and escalate
Months on therapy and side effects tracked over time. Dosing, labs and risk always go back to the prescriber.
01
Intake
Health history, medications, the hormone regimen and any prescriber-entered labs.
02
Safety check
The Clinical Reasoning Engine checks the unified patient record so no plan contradicts another drug or condition.
03
Plan
A nutritionist (Registered Dietitian Nutritionist) and a personal trainer review and approve every plan before the patient sees it.
04
Daily coaching
Meals, training sessions, sleep routines and check-ins, delivered under your brand.
05
Measure and escalate
Months on therapy and side effects tracked over time. Dosing, labs and risk always go back to the prescriber.
Markets
Who this is for.
Telehealth companies building menopause and testosterone programs, and the platforms behind them. Both will be offered as a Managed Solution or through Build It Yourself.
01
D2C Telehealth
You are building menopause and testosterone programs next. Keep those patients on therapy and subscribed, the same way you keep your GLP-1 patients.
02
Telehealth Infrastructure
One integration, and every brand on your platform can add a hormone therapy companion alongside GLP-1 with no new build.
Two ways to deploy
The same Medication Companion. You choose who runs it.
Safe Clinical AI
Safe AI you can trust with a prescription.
The same safeguards as our GLP-1 Companion.
01
Practitioner-supervised by design
A nutritionist and personal trainer review and approve every plan before it reaches the patient. Coaches handle lifestyle only. Dosing, labs and risk conversations always go to the prescriber.
02
Rule-based, not AI-generated
Clinical decisions come from rules in our clinical knowledge bases: biomarkers to conditions, conditions to protocols, drugs to protocols, and goals and conditions to foods. AI never generates a hypothesis or a protocol; it only integrates and summarizes what the rules decided.
03
Condition protocols are evidence-cited
When the Clinical Reasoning Engine identifies a condition, the protocol it recommends for that condition is backed by peer-reviewed citations. Audit-ready and inspectable.
Roadmap
Design partners wanted
Become a design partner.
We will build menopause hormone therapy first, then testosterone, with a small group of design partners. If you prescribe either therapy, work with us on the patient experience, the coaching program and the reporting before launch, and be first to offer it to your patients.
Become a design partner